First new HIV vaccine efficacy study in 7 years has begun:
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the virus.
Read the full article by here: Johannesburg, South Africa News
Submit and get free press releases here: MyPR Free Press Release.
Click HERE to submit your Johannesburg or Gauteng Press Release.
Source: MyJHB
Read more on MyJHB.
Join the fun: Add Your event | Submit a Press Release | Add your listing.
